Tirzepatide-associated improvements in cardiometabolic risk factors linked to degree of weight loss
1. In this post-hoc analysis of the SURMOUNT-1 trial, there was a mostly linear relationship between percentage change in weight ...
Tag: weight loss
Semaglutide may improve cardiovascular outcomes versus empagliflozin in patients with diabetes
1. In this retrospective cohort study, treatment with semaglutide resulted in nominally lower incidence of the composite of death, myocardial ...
Midlife weight loss is associated with decreased risk of mortality and chronic disease
1. Participants with sustained midlife weight loss from nonsurgical and nonpharmacological intervention had a decreased risk of chronic diseases beyond ...
Semaglutide improves walking ability in patients with peripheral artery disease and type 2 diabetes
1. Maximum walking distance at 52 weeks was significantly improved with semaglutide. 2. There were fewer treatment-related serious adverse events ...
4:3 intermittent fasting effective for weight loss among adults with obesity
1. In this randomized controlled trial, 4:3 intermittent fasting was associated with significantly greater weight loss compared with daily caloric ...
Glucagon-like peptide-1 receptor agonists and co-agonists safe and effective for weight loss
1. In this systematic review, glucagon-like peptide-1 receptor agonists and co-agonists were effective in inducing weight loss in overweight adults ...
The Scan by 2 Minute Medicine®: Versatile Ozempic, Healthcare Reform, Unlocking the Brain, and Chickens and the Next Pandemic:
The Scan by 2 Minute Medicine® is a pop-culture medical newsletter and exclusive benefit for 2 Minute Medicine Plus subscribers. We ...
#Visual Abstract: Semaglutide Imrpoves Weight Loss Gains and Pain Related to Knee Osteoarthritis in Patients with Obesity
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
Weight loss interventions may improve metabolic and reproductive outcomes in polycystic ovarian syndrome
1. In this systematic review and meta-analysis, weight loss interventions for overweight people with polycystic ovary syndrome were associated with ...
Altimmune: GLP-1/Glucagon Receptor Agonist Pemvidutide Preserves Lean Mass During Weight Loss
Patients on pemvidutide experienced only 21.9% of weight loss attributable to lean mass. Pemvidutide preserves muscle tissue and prioritizes fat ...
